257 related articles for article (PubMed ID: 29271479)
1. Th17, synchronically increased with T
Wang W; Wang Z; Qin Y; Tang G; Cai G; Liu Y; Zhang J; Zhang P; Shen Q; Shen L; Yu W
Clin Exp Immunol; 2018 May; 192(2):181-192. PubMed ID: 29271479
[TBL] [Abstract][Full Text] [Related]
2. Increased Circulating Th17 but Decreased CD4
Qin J; Zhou J; Fan C; Zhao N; Liu Y; Wang S; Cui X; Huang M; Guan H; Li Y; Shan Z; Teng W
Biomed Res Int; 2017; 2017():8431838. PubMed ID: 29259988
[TBL] [Abstract][Full Text] [Related]
3. Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma.
Chen T; Song D; Min Z; Wang X; Gu Y; Wei B; Yao J; Chen K; Jiang Z; Xie H; Zhou L; Zheng S
J Transl Med; 2012 Jan; 10():14. PubMed ID: 22272696
[TBL] [Abstract][Full Text] [Related]
4. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
5. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.
Wang WW; Yuan XL; Chen H; Xie GH; Ma YH; Zheng YX; Zhou YL; Shen LS
Oncotarget; 2015 Oct; 6(32):33486-99. PubMed ID: 26378021
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
7. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.
Zhou X; Su YX; Lao XM; Liang YJ; Liao GQ
Oral Oncol; 2016 Feb; 53():27-35. PubMed ID: 26631955
[TBL] [Abstract][Full Text] [Related]
8. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.
Guan H; Wan Y; Lan J; Wang Q; Wang Z; Li Y; Zheng J; Zhang X; Wang Z; Shen Y; Xie F
Sci Rep; 2016 Oct; 6():35651. PubMed ID: 27762298
[TBL] [Abstract][Full Text] [Related]
10. Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis.
Zheng M; Xing C; Xiao H; Ma N; Wang X; Han G; Chen G; Hou C; Shen B; Li Y; Wang R
Immunol Invest; 2014; 43(7):705-16. PubMed ID: 24950378
[TBL] [Abstract][Full Text] [Related]
11. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
Shen X; Li N; Li H; Zhang T; Wang F; Li Q
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
[TBL] [Abstract][Full Text] [Related]
12. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
13. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
14. Decreased CD4
Wei K; Jiang BC; Guan JH; Zhang DN; Zhang MX; Wu JL; Zhu GZ
Viral Immunol; 2018 Oct; 31(8):559-567. PubMed ID: 30067145
[TBL] [Abstract][Full Text] [Related]
15. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway.
Shao Y; Lo CM; Ling CC; Liu XB; Ng KT; Chu AC; Ma YY; Li CX; Fan ST; Man K
Cancer Lett; 2014 Dec; 355(2):264-72. PubMed ID: 25301451
[TBL] [Abstract][Full Text] [Related]
16. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
17. Loss of Gαq impairs regulatory B-cell function.
He Y; Yuan X; Li Y; Zhong C; Liu Y; Qian H; Xuan J; Duan L; Shi G
Arthritis Res Ther; 2018 Aug; 20(1):186. PubMed ID: 30143054
[TBL] [Abstract][Full Text] [Related]
18. The role of regulatory B cells (Bregs) in the Tregs-amplifying effect of Sirolimus.
Song J; Xiao L; Du G; Gao Y; Chen W; Yang S; Fan W; Shi B
Int Immunopharmacol; 2016 Sep; 38():90-6. PubMed ID: 27258186
[TBL] [Abstract][Full Text] [Related]
19. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
[TBL] [Abstract][Full Text] [Related]
20. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
